In Quebec, where one in four adults is obese, the current cost of these new drugs (approximately $500 per month) would involve an annual expenditure of several hundred million dollars (in the United States the situation is even worse: the cost of a 72-week course of tirzepatide (15 mg/week) is approximately US$17,000, while the 68-week treatment with semaglutide (2.4 mg/week) is nearly US$23,000!)
Among adults, 38.5% of Black residents have obesity, compared with 33.9% of Hispanic residents and 29.5% of white residents, according to Health in Rhode Island
Those figures are growing in part thanks to people without a history of diabetes, and in particular, a younger demographic
They might also extend the dosing interval to one dose every two weeks instead of one
Diabetes: What Raises and Lowers Your Blood Sugar Level?Want to lower your blood sugar